{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:20:20Z","timestamp":1791656420859,"version":"4.3.4"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Siksha 'O' Anusandhan Deemed To Be University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10761-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:51:29Z","timestamp":1752137489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unveiling the anticancer potential of Curcuma amada rhizome extract against prostate cancer through computational and experimental approaches"],"prefix":"10.1038","volume":"15","author":[{"given":"Arpita","family":"Priyadarshini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajani","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swagat","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rout George","family":"Kerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambika","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswabhusan","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap Chandra","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghamitra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"10761_CR1","doi-asserted-by":"publisher","first-page":"991330","DOI":"10.3389\/fcell.2022.991330","volume":"10","author":"S Belkahla","year":"2022","unstructured":"Belkahla, S., Nahvi, I., Biswas, S. & Nahvi, I. Ben amor, N. Advances and development of prostate cancer, treatment, and strategies: A systemic review. Front. Cell. Dev. Biol. 10, 991330 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3","key":"10761_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10761_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12957-025-03733-1","volume":"23","author":"F Chu","year":"2025","unstructured":"Chu, F. et al. Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040. World J. Surg. Oncol. 23 (1), 98 (2025).","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10761_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia, G. et al. Epidemiology and prevention of prostate cancer. Eur. Urol. Oncol. 4 (6), 877\u2013892 (2021).","journal-title":"Eur. Urol. Oncol."},{"issue":"5","key":"10761_CR5","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/cancers15051621","volume":"15","author":"S Gogola","year":"2023","unstructured":"Gogola, S. et al. Anti-cancer stem-cell-targeted therapies in prostate cancer. Cancers 15 (5), 1621 (2023).","journal-title":"Cancers"},{"issue":"12","key":"10761_CR6","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1200\/JCO.2006.10.1949","volume":"25","author":"DA Loblaw","year":"2007","unstructured":"Loblaw, D. A. et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 update of an American society of clinical oncology practice guideline. J. Clin. Oncol. 25 (12), 1596\u20131605 (2007).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10761_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2021","unstructured":"Cornford, P. et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer. Eur. Urol. 79 (2), 263\u2013282 (2021).","journal-title":"Eur. Urol."},{"issue":"1","key":"10761_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ctrv.2013.07.008","volume":"40","author":"S Wen","year":"2014","unstructured":"Wen, S., Niu, Y., Lee, S. O. & Chang, C. Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death. Cancer Treat. Rev. 40 (1), 31\u201340 (2014).","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10761_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1200\/JCO.2014.58.2973","volume":"33","author":"L Klotz","year":"2015","unstructured":"Klotz, L. et al. Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT. J. Clin. Oncol. 33 (10), 1151\u20131156 (2015).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10761_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.22514\/jomh.2024.181","volume":"20","author":"Y Pyo","year":"2024","unstructured":"Pyo, Y. & Kwon, K. H. Current state of prostate cancer treatment and future strategies. J. Mens Health. 20 (11), 9\u201318 (2024).","journal-title":"J. Mens Health"},{"issue":"8","key":"10761_CR11","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/molecules24081472","volume":"24","author":"Y Li","year":"2019","unstructured":"Li, Y., Pan, J. & Gou, M. The anti-proliferation, cycle arrest and apoptotic inducing activity of peperomin E on prostate cancer PC-3 cell line. Molecules 24 (8), 1472 (2019).","journal-title":"Molecules"},{"issue":"3","key":"10761_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1634\/theoncologist.9-3-295","volume":"9","author":"MH Rashid","year":"2004","unstructured":"Rashid, M. H. & Chaudhary, U. B. Intermittent androgen deprivation therapy for prostate cancer. Oncologist 9 (3), 295\u2013301 (2004).","journal-title":"Oncologist"},{"issue":"1","key":"10761_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/medicina60010077","volume":"60","author":"AB Reiss","year":"2023","unstructured":"Reiss, A. B. et al. Androgen deprivation therapy for prostate cancer: focus on cognitive function and mood. Medicina 60 (1), 77 (2023).","journal-title":"Medicina"},{"issue":"5","key":"10761_CR14","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/01.ju.0000176817.46279.93","volume":"174","author":"M Peyromaure","year":"2005","unstructured":"Peyromaure, M. et al. Management of prostate cancer in china: a multicenter report of 6 institutions. J. Urol. 174 (5), 1794\u20131797 (2005).","journal-title":"J. Urol."},{"key":"10761_CR15","doi-asserted-by":"publisher","first-page":"302426","DOI":"10.1155\/2013\/302426","volume":"2013","author":"SY Yin","year":"2013","unstructured":"Yin, S. Y., Wei, W. C., Jian, F. Y. & Yang, N. S. Therapeutic applications of herbal medicines for cancer patients. Evid. Based Complement. Alternat. Med. 2013, 302426 (2013).","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10761_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S2095-4964(14)60034-0","volume":"12","author":"ZL Liu","year":"2014","unstructured":"Liu, Z. L. et al. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis. J. Integr. Med. 12 (4), 346\u2013358 (2014).","journal-title":"J. Integr. Med."},{"key":"10761_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3389\/fphar.2018.01394","volume":"9","author":"B Fu","year":"2018","unstructured":"Fu, B. et al. Multi-component herbal products in the prevention and treatment of chemotherapy-associated toxicity and side effects: a review on experimental and clinical evidences. Front. Pharmacol. 9, 1394 (2018).","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10761_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5582\/bst.2018.01144","volume":"12","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics. Biosci. Trends. 12 (3), 220\u2013239 (2018).","journal-title":"Biosci. Trends"},{"issue":"5","key":"10761_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Qiu, H., Li, C., Cai, P. & Qi, F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci. Trends. 15 (5), 283\u2013298 (2021).","journal-title":"Biosci. Trends"},{"issue":"12","key":"10761_CR20","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/jsfa.2599","volume":"86","author":"L Hooper","year":"2006","unstructured":"Hooper, L. & Cassidy, A. A review of the health care potential of bioactive compounds. J. Sci. Food Agric. 86 (12), 1805\u20131813 (2006).","journal-title":"J. Sci. Food Agric."},{"issue":"3","key":"10761_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/01635581.2015.1004591","volume":"67","author":"P Signorelli","year":"2015","unstructured":"Signorelli, P. et al. Natural grape extracts regulate colon cancer cells malignancy. Nutr. Cancer. 67 (3), 494\u2013503 (2015).","journal-title":"Nutr. Cancer"},{"key":"10761_CR22","doi-asserted-by":"publisher","first-page":"113384","DOI":"10.1016\/j.biopha.2022.113384","volume":"153","author":"A Esmeeta","year":"2022","unstructured":"Esmeeta, A. et al. Plant-derived bioactive compounds in colon cancer treatment: an updated review. Biomed. Pharmacother. 153, 113384 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"10761_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10555-013-9457-1","volume":"33","author":"BN Singh","year":"2014","unstructured":"Singh, B. N., Singh, H. B., Singh, A., Naqvi, A. H. & Singh, B. R. Dietary phytochemicals alter epigenetic events and signaling pathways for Inhibition of metastasis cascade: phytoblockers of metastasis cascade. Cancer Metastasis Rev. 33, 41\u201385 (2014).","journal-title":"Cancer Metastasis Rev."},{"key":"10761_CR24","doi-asserted-by":"publisher","first-page":"173488","DOI":"10.1016\/j.ejphar.2020.173488","volume":"888","author":"MF Akhtar","year":"2020","unstructured":"Akhtar, M. F. et al. Anticancer natural medicines: an overview of cell signaling and other targets of anticancer phytochemicals. Eur. J. Pharmacol. 888, 173488 (2020).","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10761_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1079\/PGR200574","volume":"3","author":"B Sasikumar","year":"2005","unstructured":"Sasikumar, B. Genetic resources of Curcuma: diversity, characterization and utilization. Plant. Genet. Res. 3 (2), 230\u2013251 (2005).","journal-title":"Plant. Genet. Res."},{"issue":"1","key":"10761_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/metabo11010021","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Shukurova, M. K., Asikin, Y., Kusano, M. & Watanabe, K. N. Characterization of volatile organic compounds in Mango ginger (Curcuma amadaRoxb.) from Myanmar. Metabolites 11 (1), 21 (2020).","journal-title":"Metabolites"},{"key":"10761_CR27","doi-asserted-by":"publisher","first-page":"S405","DOI":"10.1016\/S1995-7645(14)60266-2","volume":"7","author":"S Jambunathan","year":"2014","unstructured":"Jambunathan, S., Bangarusamy, D., Padma, P. R. & &Sundaravadivelu, S. Cytotoxic activity of the methanolic extract of leaves and rhizomes of Curcuma amadaRoxb against breast cancer cell lines. Asian Pac. J. Trop. Med. 7, S405\u2013S409 (2014).","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"11","key":"10761_CR28","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.52711\/0974-360X.2022.00833","volume":"15","author":"VS Patil","year":"2022","unstructured":"Patil, V. S., Varashree, B. S., Pai, K., Hari, G. & Keerthi, P. Cytotoxic effects of Chloroform-methanol extract, protein extract and various fractions of ethanolic extract of Curcuma amada rhizome on HCT116 colon cancer cell line. Res. J. Pharm. Technol. 15 (11), 4955\u20134958 (2022).","journal-title":"Res. J. Pharm. Technol."},{"issue":"2","key":"10761_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/2156587216659390","volume":"22","author":"C Ramachandran","year":"2017","unstructured":"Ramachandran, C. et al. In vivo antitumor effect of supercritical CO2 extract of mango ginger (Curcuma amadaRoxb) in U-87MG human glioblastoma nude mice xenografts. J. Evid. Based Complement. Alternat. Med. 22(2), 260\u2013267 (2017).","journal-title":"J. Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10761_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nchembio.1199","volume":"9","author":"M Schenone","year":"2013","unstructured":"Schenone, M., Dan\u010d\u00edk, V., Wagner, B. K. & Clemons, P. A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9 (4), 232\u2013240 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"10761_CR31","first-page":"127","volume":"35","author":"U Chandran","year":"2016","unstructured":"Chandran, U., Mehendale, N., Patil, S., Chaguturu, R. & Patwardhan, B. Network pharmacology. Innov. Appr. Drug Discov. 35, 127 (2016).","journal-title":"Innov. Appr. Drug Discov."},{"issue":"5","key":"10761_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ph15050572","volume":"15","author":"F Noor","year":"2022","unstructured":"Noor, F. et al. Network Pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals 15 (5), 572 (2022).","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10761_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/ph16010120","volume":"16","author":"MHR Molla","year":"2023","unstructured":"Molla, M. H. R. et al. Integrative ligand-based pharmacophore modeling, virtual screening, and molecular Docking simulation approaches identified potential lead compounds against pancreatic cancer by targeting FAK1. Pharmaceuticals 16 (1), 120 (2023).","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10761_CR34","doi-asserted-by":"publisher","first-page":"31664","DOI":"10.1038\/s41598-024-81037-2","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. Computational biology assisted exploration of phytochemicals derived natural inhibitors to block BZLF1 gene activation of Epstein\u2013Bar virus in host. Sci. Rep. 14 (1), 31664 (2024).","journal-title":"Sci. Rep."},{"issue":"20","key":"10761_CR35","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: an integrated repository portal for tumor\u2013immune system interactions. Bioinformatics 35 (20), 4200\u20134202 (2019).","journal-title":"Bioinformatics"},{"key":"10761_CR36","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.3390\/molecules16064539","volume":"8","author":"SNA Malek","year":"2011","unstructured":"Malek, S. N. A. et al. Phytochemical and cytotoxic investigations of Curcuma Mangga rhizomes. Molecules 8, 4539\u20134548 (2011).","journal-title":"Molecules"},{"key":"10761_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0031-9422(00)89800-3","volume":"36","author":"HM Sirat","year":"1994","unstructured":"Sirat, H. M., Masri, D. & Rahman, A. A. The distribution of labdane diterpenes in the Zingiberaceae of Malaysia. Phytochemistry 36, 699\u2013701 (1994).","journal-title":"Phytochemistry"},{"key":"10761_CR38","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1021\/np970243d","volume":"60","author":"LK Sy","year":"1997","unstructured":"Sy, L. K. & Brown, G. D. Labdane diterpenoids from Alpinia chinensis. J. Nat. Prod. 60, 904\u2013908 (1997).","journal-title":"J. Nat. Prod."},{"key":"10761_CR39","first-page":"60","volume":"15","author":"M Hao","year":"2019","unstructured":"Hao, M. et al. Metabolic profiling analysis of three processed rhizomes of Curcuma wenyujin YH Chen et C. Ling by ultra-performance liquid chromatography\/time-of-flight mass spectrometry. Pharmacogn. Mag. 15, 60 (2019).","journal-title":"Pharmacogn. Mag."},{"issue":"4","key":"10761_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jpha.2017.01.005","volume":"7","author":"S Kumar","year":"2017","unstructured":"Kumar, S., Singh, A. & Kumar, B. Identification and characterization of phenolics and terpenoids from ethanolic extracts of Phyllanthus species by HPLC-ESI-QTOF-MS\/MS. J. Pharm. Anal. 7 (4), 214\u2013222 (2017).","journal-title":"J. Pharm. Anal."},{"issue":"5","key":"10761_CR41","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/molecules24050942","volume":"24","author":"H Lin","year":"2019","unstructured":"Lin, H. et al. Comparative analysis of chemical constituents of Moringa oleifera leaves from China and India by ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. Molecules 24 (5), 942 (2019).","journal-title":"Molecules"},{"issue":"19","key":"10761_CR42","first-page":"3304","volume":"38","author":"HE Yuan","year":"2013","unstructured":"Yuan, H. E., Zhou, X. D., Meng, L. J., Qin, F. M. & Zhou, G. X. Chemical constituents from Commelina communis. Zhongguo Zhong Yao Za zhi = ZhongguoZhongyaoZazhi = China J. Chin. Materia Med. 38 (19), 3304\u20133308 (2013).","journal-title":"Zhongguo Zhong Yao Za zhi = ZhongguoZhongyaoZazhi = China J. Chin. Materia Med."},{"issue":"7","key":"10761_CR43","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/chromsci\/bmy007","volume":"56","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Simultaneous qualitative and quantitative study of main compounds in Commelina communis linn. By UHPLC\u2013Q-TOF-MS-MS and HPLC\u2013ESI-MS-MS. J. Chromatogr. Sci. 56 (7), 582\u2013594 (2018).","journal-title":"J. Chromatogr. Sci."},{"issue":"9","key":"10761_CR44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bse.2007.02.002","volume":"35","author":"Q Yang","year":"2007","unstructured":"Yang, Q., Ye, G. & Zhao, W. M. Chemical constituents of Commelina communis Linn. Biochem. Syst. Ecol. 35 (9), 621\u2013623 (2007).","journal-title":"Biochem. Syst. Ecol."},{"key":"10761_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0021-9673(98)00540-8","volume":".818","author":"XGLLZ He","year":"1998","unstructured":"He, X. G. L. L. Z., Lian, L. Z. & &Lindenmaier, M. Liquid chromatography\u2013electrospray mass spectrometric analysis of curcuminoids and sesquiterpenoids in turmeric (Curcuma longa). J. Chromatogr. A. .818, 127\u2013132 (1998).","journal-title":"J. Chromatogr. A"},{"key":"10761_CR46","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpba.2013.03.027","volume":"81\u201382","author":"Y Shen","year":"2013","unstructured":"Shen, Y., Han, C., Chen, X., Hou, X. & Long, Z. Simultaneous determination of three curcuminoids in Curcuma wenyujinY.H.chen et c.ling. By liquid chromatography tandem mass spectrometry combined with pressurized liquid extraction. J. Pharm. Biomed. Anal. 81\u201382, 146\u2013150 (2013).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"D1","key":"10761_CR47","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10761_CR48","doi-asserted-by":"publisher","first-page":"015003","DOI":"10.1088\/2057-1739\/aaa00b","volume":"4","author":"PD Malihi","year":"2018","unstructured":"Malihi, P. D. et al. Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis. Converg Sci. Phys. Oncol. 4 (1), 015003 (2018).","journal-title":"Converg Sci. Phys. Oncol."},{"key":"10761_CR49","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.semcancer.2016.06.003","volume":"40\u201341","author":"G Kallifatidis","year":"2016","unstructured":"Kallifatidis, G., Hoy, J. J. & Lokeshwar, B. L. Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer. Semin Cancer Biol. 40\u201341, 160\u2013169 (2016).","journal-title":"Semin Cancer Biol."},{"key":"10761_CR50","first-page":"1588","volume":"7","author":"WF Taylor","year":"2017","unstructured":"Taylor, W. F. & &Jabbarzadeh, E. The use of natural products to target cancer stem cells. Am. J. Cancer Res. 7, 1588\u20131605 (2017).","journal-title":"Am. J. Cancer Res."},{"key":"10761_CR51","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/nu11071483","volume":"11","author":"B Salehi","year":"2019","unstructured":"Salehi, B. et al. Phytochemicals in prostate cancer: from bioactive molecules to upcoming therapeutic agents. Nutrients 11, 1483 (2019).","journal-title":"Nutrients"},{"key":"10761_CR52","unstructured":"Siddaraju, M. N. Antiulcer And Anticancer Bioactive Compounds From Ginger (Zingiber officinale) And Mango Ginger (Curcuma amada) (Doctoral dissertation, University of Mysore) (2008)."},{"issue":"2","key":"10761_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/2156587214563731","volume":"20","author":"C Ramachandran","year":"2015","unstructured":"Ramachandran, C., Lollett, I. V., Escalon, E., Quirin, K. W. & Melnick, S. J. Anticancer potential and mechanism of action of Mango ginger (Curcuma amadaRoxb.) supercritical CO2 extract in human glioblastoma cells. J. Evid. Based Complement. Alternat Med. 20 (2), 109\u2013119 (2015).","journal-title":"J. Evid. Based Complement. Alternat Med."},{"issue":"21","key":"10761_CR54","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2174\/0929867331666230809100335","volume":"31","author":"A Noor","year":"2024","unstructured":"Noor, A. et al. Curcuminoids as cell signaling pathway modulators: a potential strategy for cancer prevention. Curr. Med. Chem. 31 (21), 3093\u20133117 (2024).","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10761_CR55","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1081\/JLC-100101751","volume":"22","author":"AP Gupta","year":"1999","unstructured":"Gupta, A. P., Gupta, M. M. & Kumar, S. Simultaneous determination of curcuminoids in Curcuma samples using high performance thin layer chromatography. J. Liq Chromatogr. R Technol. 22 (10), 1561\u20131569 (1999).","journal-title":"J. Liq Chromatogr. R Technol."},{"key":"10761_CR56","first-page":"51","volume":"11","author":"TS Al-Qudah","year":"2017","unstructured":"Al-Qudah, T. S. et al. Mango ginger (Curcuma amadaRoxb.): A phytochemical mini review. IJCBS 11, 51\u201357 (2017).","journal-title":"IJCBS"},{"key":"10761_CR57","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.phytochem.2013.08.004","volume":"96","author":"A Schramm","year":"2013","unstructured":"Schramm, A. et al. Phytochemical profiling of Curcuma Kwangsiensis rhizome extract, and identification of labdane diterpenoids as positive GABAA receptor modulators. Phytochemistry 96, 318\u2013329 (2013).","journal-title":"Phytochemistry"},{"key":"10761_CR58","unstructured":"Hamdi, O. A. A. Chemical Constituents from the Rhizomes of Curcuma zedoaria and Curcuma Purpurascens and Assessment of their Biological Activities (University of Malaya (Malaysia), 2015)."},{"issue":"1","key":"10761_CR59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41598-020-79414-8","volume":"11","author":"T Soumya","year":"2021","unstructured":"Soumya, T., Lakshmipriya, T., Klika, K. D., Jayasree, P. R. & Manish Kumar, P. R. Anticancer potential of rhizome extract and a labdane diterpenoid from Curcuma mutabilis plant endemic to Western Ghats of India. Sci. Rep. 11 (1), 552 (2021).","journal-title":"Sci. Rep."},{"issue":"12","key":"10761_CR60","first-page":"1934578X1801301","volume":"13","author":"S Anuchapreeda","year":"2018","unstructured":"Anuchapreeda, S. et al. Characterization and biological properties of Zederone and Zedoarondiol from rhizomes of En-lueang (Curcuma cf. amada). Nat. Prod. Commun. 13 (12), 1934578X1801301211 (2018).","journal-title":"Nat. Prod. Commun."},{"issue":"1","key":"10761_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.foodchem.2011.08.054","volume":"131","author":"S Singh","year":"2012","unstructured":"Singh, S., Singh, R., Banerjee, S., Negi, A. S. & Shanker, K. Determination of anti-tubercular agent in Mango ginger (Curcuma amadaRoxb.) by reverse phase HPLC-PDA-MS. Food Chem. 131 (1), 375\u2013379 (2012).","journal-title":"Food Chem."},{"key":"10761_CR62","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s12161-015-0110-1","volume":"8","author":"M Rafi","year":"2015","unstructured":"Rafi, M. et al. Curcuminoid\u2019s content and fingerprint analysis for authentication and discrimination of Curcuma xanthorrhiza from Curcuma longa by high-performance liquid chromatography-diode array detector. Food Anal. Methods. 8, 2185\u20132193 (2015).","journal-title":"Food Anal. Methods"},{"key":"10761_CR63","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ultsonch.2017.03.040","volume":"38","author":"SR Shirsath","year":"2017","unstructured":"Shirsath, S. R. et al. Intensification of extraction of Curcumin from Curcuma amada using ultrasound assisted approach: effect of different operating parameters. Ultrason. Sonochem. 38, 437\u2013445 (2017).","journal-title":"Ultrason. Sonochem"},{"key":"10761_CR64","first-page":"87","volume":"219","author":"J Akter","year":"2019","unstructured":"Akter, J., Islam, M. Z., Takara, K., Hossain, M. A. & Sano, A. Isolation and structural Elucidation of antifungal compounds from Ryudai gold (Curcuma longa) against Fusarium solanisensu Lato isolated from American manatee. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 219, 87\u201394 (2019).","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"issue":"11","key":"10761_CR65","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/carcin\/bgh233","volume":"25","author":"GP Collett","year":"2004","unstructured":"Collett, G. P. & Campbell, F. C. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25 (11), 2183\u20132189 (2004).","journal-title":"Carcinogenesis"},{"issue":"3","key":"10761_CR66","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yexmp.2008.02.002","volume":"84","author":"JL Watson","year":"2008","unstructured":"Watson, J. L., Hill, R., Lee, P. W., Giacomantonio, C. A. & Hoskin, D. W. Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Exp. Mol. Pathol. 84 (3), 230\u2013233 (2008).","journal-title":"Exp. Mol. Pathol."},{"issue":"4","key":"10761_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.7962","volume":"45","author":"H Zhou","year":"2021","unstructured":"Zhou, H., Ning, Y., Zeng, G., Zhou, C. & Ding, X. Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT. Oncol. Rep. 45 (4), 1\u20131 (2021).","journal-title":"Oncol. Rep."},{"key":"10761_CR68","doi-asserted-by":"publisher","first-page":"122682","DOI":"10.1016\/j.lfs.2024.122682","volume":"347","author":"R Xie","year":"2024","unstructured":"Xie, R. et al. Homogentisic acid metabolism inhibits papillary thyroid carcinoma proliferation through ROS and p21-induced cell cycle arrest. Life Sci. 347, 122682 (2024).","journal-title":"Life Sci."},{"issue":"4","key":"10761_CR69","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.phytol.2009.06.003","volume":"2","author":"N Chimnoi","year":"2009","unstructured":"Chimnoi, N. et al. Phytochemical reinvestigation of labdane-type diterpenes and their cytotoxicity from the rhizomes of Hedychium coronarium. Phytochem Lett. 2 (4), 184\u2013187 (2009).","journal-title":"Phytochem Lett."},{"key":"10761_CR70","first-page":"755","volume":"5","author":"MS Alavijeh","year":"2004","unstructured":"Alavijeh, M. S. & Palmer, A. M. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines. Curr. Opin. Investig Drugs. 5, 755\u2013763 (2004).","journal-title":"Curr. Opin. Investig Drugs"},{"issue":"1","key":"10761_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2013.12.003","volume":".4","author":"S Basavaraj","year":"2014","unstructured":"Basavaraj, S. & &Betageri, G. V. Can formulation and drug delivery reduce attrition during drug discovery and development\u2014review of feasibility, benefits and challenges. Acta Pharm. Sin B. .4 (1), 3\u201317 (2014).","journal-title":"Acta Pharm. Sin B"},{"issue":"4","key":"10761_CR72","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.eururo.2013.05.029","volume":"64","author":"CE Barbieri","year":"2013","unstructured":"Barbieri, C. E. et al. The mutational landscape of prostate cancer. Eur. Urol. 64 (4), 567\u2013576 (2013).","journal-title":"Eur. Urol."},{"issue":"5","key":"10761_CR73","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161 (5), 1215\u20131228 (2015).","journal-title":"Cell"},{"issue":"9","key":"10761_CR74","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/pros.24135","volume":"81","author":"E Nizialek","year":"2021","unstructured":"Nizialek, E. et al. Genomic profiles and clinical outcomes in primary versus secondary metastatic hormone-sensitive prostate cancer. Prostate 81 (9), 572\u2013579 (2021).","journal-title":"Prostate"},{"issue":"1","key":"10761_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13000-024-01511-3","volume":"19","author":"D Akhoundova","year":"2024","unstructured":"Akhoundova, D. et al. Rare histologic transformation of a CTNNB1 (\u03b2-catenin) mutated prostate cancer with aggressive clinical course. Diagn. Pathol. 19 (1), 83 (2024).","journal-title":"Diagn. Pathol."},{"key":"10761_CR76","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1158\/1078-0432.CCR-07-1257","volume":"13","author":"T Schlomm","year":"2007","unstructured":"Schlomm, T. et al. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin. Cancer Res. 13, 6579\u20136584 (2007).","journal-title":"Clin. Cancer Res."},{"key":"10761_CR77","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/0008-5472.CAN-16-1656","volume":"77","author":"KC Day","year":"2017","unstructured":"Day, K. C. et al. HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone. Cancer Res. 77, 74\u201385 (2017).","journal-title":"Cancer Res."},{"issue":"12","key":"10761_CR78","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/s41416-020-01052-8","volume":"123","author":"P Nasta\u0142y","year":"2020","unstructured":"Nasta\u0142y, P. et al. EGFR as a stable marker of prostate cancer dissemination to bones. Br. J. Cancer. 123 (12), 1767\u20131774 (2020).","journal-title":"Br. J. Cancer"},{"issue":"18","key":"10761_CR79","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3390\/cells12182207","volume":"12","author":"L Armstrong","year":"2023","unstructured":"Armstrong, L., Willoughby, C. E. & McKenna, D. J. Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer. Cells. 12(18), 2207 (2023).","journal-title":"Cells."},{"key":"10761_CR80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1158\/1055-9965.EPI-06-0767","volume":"16","author":"JM Cunningham","year":"2007","unstructured":"Cunningham, J. M. et al. Evaluation of genetic variations in the androgen and Estrogen metabolic pathways as risk factors for sporadic and Familial prostate cancer. Cancer Epidemiol. Biomarkers Prev. 16, 969\u2013978 (2007).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10761_CR81","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-08-0321","volume":"160","author":"N Nicolaiew","year":"2009","unstructured":"Nicolaiew, N. et al. Association between Estrogen and androgen receptor genes and prostate cancer risk. Eur. J. Endocrinol. 160, 101\u2013106 (2009).","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10761_CR82","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cdp.2003.12.009","volume":"28","author":"H Zhong","year":"2004","unstructured":"Zhong, H., Semenza, G. L., Simons, J. W. & De Marzo, A. M. Up-regulation of hypoxia-inducible factor 1\u03b1 is an early event in prostate carcinogenesis. Cancer Detect. Prev. 28 (2), 88\u201393 (2004).","journal-title":"Cancer Detect. Prev."},{"issue":"2","key":"10761_CR83","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/jcp.29078","volume":"235","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. MicroRNA-487a\u20103p functions as a new tumor suppressor in prostate cancer by targeting CCND1. J. Cell. Physiol. 235 (2), 1588\u20131600 (2020).","journal-title":"J. Cell. Physiol."},{"key":"10761_CR84","first-page":"4438","volume":"55","author":"AJ Raffo","year":"1995","unstructured":"Raffo, A. J. et al. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55, 4438\u20134444 (1995).","journal-title":"Cancer Res."},{"issue":"1","key":"10761_CR85","doi-asserted-by":"publisher","first-page":"13145","DOI":"10.1038\/s41598-024-63970-4","volume":"14","author":"Y Lyu","year":"2024","unstructured":"Lyu, Y. et al. Zedoarondiol inhibits human bronchial smooth muscle cell proliferation through the CAV-1\/PDGF signalling pathway. Sci. Rep. 14 (1), 13145 (2024).","journal-title":"Sci. Rep."},{"issue":"7","key":"10761_CR86","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1289\/ehp.0900613","volume":"117","author":"W Winuthayanon","year":"2009","unstructured":"Winuthayanon, W. et al. Diarylheptanoid phytoestrogens isolated from the medicinal plant Curcuma comosa: biologic actions in vitro and in vivo indicate Estrogen receptor-dependent mechanisms. Environ. Health Perspect. 117 (7), 1155\u20131161 (2009).","journal-title":"Environ. Health Perspect."},{"issue":"6","key":"10761_CR87","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.3390\/molecules16064539","volume":"16","author":"SNA Malek","year":"2011","unstructured":"Malek, S. N. A. et al. Phytochemical and cytotoxic investigations of Curcuma Mangga rhizomes. Molecules 16 (6), 4539\u20134548 (2011).","journal-title":"Molecules"},{"issue":"8","key":"10761_CR88","first-page":"1934578X2311938","volume":"18","author":"AR Aikins","year":"2023","unstructured":"Aikins, A. R. et al. Caffeic acid inhibits proliferation, migration, and stemness of DU-145 prostate Cancer cells. Nat. Prod. Commun. 18 (8), 1934578X231193848 (2023).","journal-title":"Nat. Prod. Commun."},{"issue":"6","key":"10761_CR89","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/ijms17060837","volume":"17","author":"M K\u0142\u00f3sek","year":"2016","unstructured":"K\u0142\u00f3sek, M. et al. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells after treatment with xanthohumol\u2014A natural compound present in Humulus lupulus L. Int. J. Mol. Sci. 17 (6), 837 (2016).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10761_CR90","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/13543784.2018.1558202","volume":"28","author":"F Barra","year":"2019","unstructured":"Barra, F. et al. Investigational PI3K\/AKT\/mTOR inhibitors in development for endometrial cancer. Expert Opin. Investig Drugs. 28 (2), 131\u2013142 (2019).","journal-title":"Expert Opin. Investig Drugs"},{"key":"10761_CR91","doi-asserted-by":"publisher","first-page":"819128","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng, Y., Wang, Y., Zhou, C., Mei, W. & Zeng, C. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway? Front. Oncol. 12, 819128 (2022).","journal-title":"Front. Oncol."},{"issue":"6","key":"10761_CR92","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2174\/1871520614666140521121317","volume":"14","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. The effect of lycopene on the PI3K\/Akt signalling pathway in prostate cancer. Anti-Cancer Agents Med. Chem. 14 (6), 800\u2013805 (2014).","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"5","key":"10761_CR93","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/jcb.25729","volume":"118","author":"W Lim","year":"2017","unstructured":"Lim, W., Park, S., Bazer, F. W. & Song, G. Naringenin-induced apoptotic cell death in prostate cancer cells is mediated via the PI3K\/AKT and MAPK signaling pathways. J. Cell. Biochem. 118 (5), 1118\u20131131 (2017).","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10761_CR94","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/cancers16081554","volume":"16","author":"V Zoi","year":"2024","unstructured":"Zoi, V. et al. The role of Curcumin in cancer: a focus on the PI3K\/Akt pathway. Cancers 16 (8), 1554 (2024).","journal-title":"Cancers"},{"issue":"10","key":"10761_CR95","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1111\/cas.15062","volume":"112","author":"HB Zhao","year":"2021","unstructured":"Zhao, H. B. et al. Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma. Cancer Sci. 112 (10), 4365\u20134376 (2021).","journal-title":"Cancer Sci."},{"issue":"1","key":"10761_CR96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000362332","volume":"164","author":"WH Fridman","year":"2014","unstructured":"Fridman, W. H. et al. The immune microenvironment: a major player in human cancers. Int. Arch. Allergy Immunol. 164 (1), 13\u201326 (2014).","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"10761_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pros.20431","volume":"67","author":"S Alessandro","year":"2007","unstructured":"Alessandro, S. et al. Characterization of Circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients. Prostate 67 (1), 1\u20137 (2007).","journal-title":"Prostate"},{"key":"10761_CR98","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2021.10.027","volume":"525","author":"C Wang","year":"2022","unstructured":"Wang, C., Zhang, Y. & Gao, W. Q. The evolving role of immune cells in prostate cancer. Cancer Lett. 525, 9\u201321 (2022).","journal-title":"Cancer Lett."},{"issue":"2","key":"10761_CR99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","volume":"36","author":"YC Chen","year":"2015","unstructured":"Chen, Y. C. Beware of docking! Trends Pharmacol. Sci. 36 (2), 78\u201395 (2015).","journal-title":"Trends Pharmacol. Sci."},{"issue":"16","key":"10761_CR100","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem. Rev. 119 (16), 9478\u20139508 (2019).","journal-title":"Chem. Rev."},{"issue":"15","key":"10761_CR101","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.3390\/cancers13153698","volume":"13","author":"A Makimoto","year":"2021","unstructured":"Makimoto, A., Fang, J. & Maeda, H. Development of a selective tumor-targeted drug delivery system: Hydroxypropyl-acrylamide polymer-conjugated pirarubicin (P-THP) for pediatric solid tumors. Cancers 13 (15), 3698 (2021).","journal-title":"Cancers"},{"key":"10761_CR102","first-page":"1","volume":"86","author":"S Erg\u00fcn","year":"2024","unstructured":"Erg\u00fcn, S. et al. Beyond death: Unmasking the intricacies of apoptosis Escape. Mol. Diagn. Ther. 86, 1\u201321 (2024).","journal-title":"Mol. Diagn. Ther."},{"key":"10761_CR103","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1073\/pnas.94.7.2776","volume":"94(7)","author":"K Collins","year":"1997","unstructured":"Collins, K., Jacks, T. & Pavletich, N. P. The cell cycle and cancer. Proc. Nat. Acad. Sci. 94(7), 2776\u20132778 (1997).","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"5","key":"10761_CR104","first-page":"871","volume":"16","author":"E McDonald","year":"2000","unstructured":"McDonald, E. & El-Deiry, W. S. Cell cycle control as a basis for cancer drug development. Int. J. Oncol. 16 (5), 871\u2013957 (2000).","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10761_CR105","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/1381612003400948","volume":"6","author":"JK Buolamwini","year":"2000","unstructured":"Buolamwini, J. K. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6 (4), 379\u2013392 (2000).","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10761_CR106","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/1535-7163.933.3.8","volume":"3","author":"VM Adhami","year":"2004","unstructured":"Adhami, V. M. et al. Sanguinarine causes cell cycle Blockade and apoptosis of human prostate carcinoma cells via modulation of Cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol. Cancer Ther. 3 (8), 933\u2013940 (2004).","journal-title":"Mol. Cancer Ther."},{"issue":"31","key":"10761_CR107","doi-asserted-by":"publisher","first-page":"50747","DOI":"10.18632\/oncotarget.17096","volume":"8","author":"A Hu","year":"2017","unstructured":"Hu, A. et al. Curcumin induces G2\/M cell cycle arrest and apoptosis of head and neck squamous cell carcinoma in vitro and in vivo through ATM\/Chk2\/p53-dependent pathway. Oncotarget 8 (31), 50747 (2017).","journal-title":"Oncotarget"},{"key":"10761_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-017-0400-3","volume":"17","author":"NM Ali","year":"2017","unstructured":"Ali, N. M. et al. Synthetic Curcumin derivative DK1 possessed G2\/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells. Cancer Cell. Int. 17, 1\u201312 (2017).","journal-title":"Cancer Cell. Int."},{"issue":"4","key":"10761_CR109","first-page":"905","volume":"30","author":"S Shankar","year":"2007","unstructured":"Shankar, S. & Srivastava, R. K. Involvement of Bcl-2 family members, phosphatidylinositol 3\u2019-kinase\/AKT and mitochondrial p53 in Curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int. J. Oncol. 30 (4), 905\u2013918 (2007).","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10761_CR110","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.3892\/or.2015.4258","volume":"34","author":"H Jin","year":"2015","unstructured":"Jin, H., Qiao, F., Wang, Y., Xu, Y. & Shang, Y. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K\/Akt signaling pathway. Oncol. Rep. 34 (5), 2782\u20132789 (2015).","journal-title":"Oncol. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10761-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:20:52Z","timestamp":1757218852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10761-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10761"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10761-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve any ethical issues.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"24739"}}